Craig Ritchie is an internationally renowned researcher in the field of dementia with a reputation for the design and prosecution of dementia clinical trials, epidemiology of mid-life risk and diagnostic tests. He has been Principal Investigator in almost 30 commercial trials in AD, National Chief Investigator in 15 in the UK and Global Coordinating Investigator on 6. Craig’s skills, credibility and leadership experience make him the ideal person to lead EPAD.